Takip et
yunus emre eksi
yunus emre eksi
Tıbbi Biyoloji ve Genetik AD. Araştırma görevlisi Akdeniz Üniversitesi
akdeniz.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes
HM Tasyurek, YE Eksi, AD Sanlioglu, HA Altunbas, MK Balci, TS Griffith, ...
Gene therapy 25 (4), 269-283, 2018
92018
Current update on severe acute respiratory syndrome coronavirus 2 vaccine development with a special emphasis on gene therapy viral vector design and construction for vaccination
A Bisgin, AD Sanlioglu, YE Eksi, TS Griffith, S Sanlioglu
Human Gene Therapy 32 (11-12), 541-562, 2021
72021
Lentivirus mediated pancreatic beta-cell-specific insulin gene therapy for STZ-induced diabetes
F Erendor, YE Eksi, EO Sahin, MK Balci, TS Griffith, S Sanlioglu
Molecular Therapy 29 (1), 149-161, 2021
62021
Myeloperoxidase and glutamate-cysteine ligase polymorphisms in type 2 diabetes mellitus: a preliminary study
YE Eksi, ZE Karaali, K Ïncekara, HA Ergen
Journal of Medical Biochemistry 33 (2), 156-161, 2014
22014
ESGCT XXV Anniversary Congress in Collaboration with the German Society for Gene Therapy October 17–20, 2017 Berlin, Germany
SM Maffioletti, S Sarcar, A Henderson, I Mannhardt, L Pinton, LA Moyle, ...
Human Gene Therapy 28 (12), A1-A125, 2017
12017
Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology
YE Eksi, AD Sanlioglu, B Akkaya, BE Ozturk, S Sanlioglu
World Journal of Stem Cells 13 (6), 485, 2021
2021
Combined Efficacy of Insulin and Anti-Inflammatory Gene Therapies for Type 1 Diabetes Mellitus
F Erendor, YE Eksi, EO Sahin, MK Balci, TS Griffith, S Sanlioglu
MOLECULAR THERAPY 29 (4), 239-240, 2021
2021
Current update on SARS-CoV-2 vaccine development with a special emphasis on gene therapy viral vector design and construction for vaccination.
A Bisgin, AD Sanlioglu, YE Eksi, TS Griffith, S Sanlioglu
Human Gene Therapy, 2021
2021
WJSC
YE Eksi, AD Sanlioglu, B Akkaya, BE Ozturk, S Sanlioglu, LS Popovic, ...
2021
Lentivirus mediated insulin promoter directed insulin gene expression is effective in suppressing postprandial glucose excursions in Type 1 diabetes
YE Eksi, F Erendor, EO Sahin, MK Balci, S Sanlioglu
HUMAN GENE THERAPY 30 (11), A154-A155, 2019
2019
Changing the Face of Modern Medicine: Stem Cell and Gene Therapy Organized Jointly by the European Society of Gene & Cell Therapy (ESGCT), International Society for Stem Cell …
KM Champion, P Albertini, I Visigalli, F Cecere, N Carriglio, ...
Human Gene Therapy 29 (12), A1-A169, 2018
2018
Development of MODY10 diabetic experimental animal model using CRISPR/Cas9 technology for insulin gene transfer studies
YE Eksi, HA Altunbas, S Sanlioglu
HUMAN GENE THERAPY 28 (12), A48-A49, 2017
2017
Generation of a lentiviral vector encoding human insulin for diabetes treatment
YE Eksi, MK Balci, S Sanlioglu
HUMAN GENE THERAPY 27 (11), A156-A156, 2016
2016
Novel approaches for insulin mediated gene delivery in diabetes treatment
YE Eksi, MK Balci, S Sanlioglu
HUMAN GENE THERAPY 27 (11), A156-A156, 2016
2016
Changing the Face of Modern Medicine: Stem Cells and Gene Therapy Florence, Italy October 18–21, 2016 Abstracts
JC Ramírez, AB del Campo, A Pañeda, I Jiménez, A Berlanga, A Mork, ...
Human Gene Therapy 27 (11), A1-A185, 2016
2016
ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts
S Sultan, A Reginald, MJ Evans, P Antonitsis, S Westaby, K Anastasiadis, ...
Human Gene Therapy 26 (10), A-1-A-108, 2015
2015
ESGCT and NVGCT Collaborative Congress: The Hague-23 to 26 October Abstracts
E Vroom, A Aartsma-Rus, RC Hoeben, H Büning, H Abken, M Pegtel, ...
Human Gene Therapy 25 (11), A1-A121, 2014
2014
Induction of Diet Induced Obesity in Sprague Dawley Rats as a Model for Type 2 Diabetes
YE Eksi, HM Tasyurek, HA Altunbas, S Sanlioglu
HUMAN GENE THERAPY 25 (11), A60-A61, 2014
2014
Comparative efficacy of diet induced obesity in C57BL/6J versus Balb/C mice for gene therapy applications
YE Eksi, HM Tasyurek, AD Sanlioglu, MK Balci, S Sanlioglu
HUMAN GENE THERAPY 25 (11), A60-A60, 2014
2014
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
HM Tasyurek, YE Eksi, HA Altunbas, MK Balci, S Sanlioglu
HUMAN GENE THERAPY 25 (11), A87-A88, 2014
2014
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20